External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage-Reference-Cited by-同舟云学术

External Reference Pricing for Pharmaceuticals—A Survey and Literature Review to Describe Best Practices for Countries With Expanding Healthcare Coverage

Published:2019-09 Issue: Volume:19 Page:122-131
ISSN:2212-1099
Container-title:Value in Health Regional Issues
language:en
Short-container-title:Value in Health Regional Issues

Author:

Holtorf Anke-Peggy,Gialama Fotini,Wijaya Kalman Emry,Kaló Zoltán

Funder

Abbott Products Operations AG

Publisher

Elsevier BV

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Economics, Econometrics and Finance (miscellaneous)

Reference41 articles.

1. Overview of external reference pricing systems in Europe;Rémuzat;J Mark Access Health Policy,2015

2. The implementation of external reference pricing within and across country borders;Kanavos,2017

3. The end of the international reference pricing system?;Persson;Appl Health Econ Health Policy,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pricing Personalised Drugs: Comparing Indication Value Based Prices with Performance Based Schemes;The B.E. Journal of Economic Analysis & Policy;2024-03-07

2. Comparative price analysis of biological medicines: disparities generated by different pricing policies;Frontiers in Pharmacology;2024-01-11

3. Knowledge management for supply chain resilience in pharmaceutical industry: evidence from the Middle East region;The International Journal of Logistics Management;2023-07-14

4. How does external reference pricing work in developing countries: evidence from Iran;Frontiers in Pharmacology;2023-06-20

5. An Industry Survey on Unmet Needs in South Korea’s New Drug Listing System;Therapeutic Innovation & Regulatory Science;2023-05-14